87 EZETIMIBE/SIMVASTATIN 10/40MG VERSUS ATORVASTATIN 40MG IN HIGH CARDIOVASCULAR RISK PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY
| Autor: | Civeira, F., Dan, A.G., Hing, P.L.K., Hanson, M.E., Massaad, R., Milardo, C., Triscari, J. |
|---|---|
| Zdroj: | In Atherosclerosis (Supplements) (Component) June 2011 12(1):21-21 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect